ArticleJournal of neurology2024

In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting.

Simona Malucchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.